World-renowned scientists and clinicians gathered at the 16th annual International Symposium of Pediatric Neuro-Oncology (ISPNO) meeting in 2014 to share developments in the pediatric brain cancer research arena. With a dedicated Low Grade Glioma Workshop and Symposium, presentations were delivered on the following topics:
- Low Grade Glioma Biology: Dr. Stefan Pfister, Director of Pediatric Neurooncology at the German Cancer Research Center, Heidelberg
- Targeted Therapies for Pediatric Low Grade Astrocytoma: Dr. Charles Stiles, Co-Chair, Department of Cancer Biology and Co-Director, Program in Pediatric Low-Grade Astrocytoma, Dana Farber Cancer Institute
- The Role of Biology in the Clinic: Dr. Mark Kieran, Director of Pediatric Medical Neuro-Oncology and Co-Director, Program in Pediatric Low-Grade Astrocytoma, Dana Farber Cancer Institute
Videos for each of the three presentations are available by clicking on the respective titles above.
In addition, the the program included LGG lectures as follows:
- A randomized trial of intensification of induction-chemotherapy within an 18 months treatment-strategy on tumor-response at 24 weeks and progression-free-survival in pediatric low grade glioma(LGG) – preliminary results of the SIOP-LGG-2004-working-group
- Nerve growth factor administration as eye drop improves visual function in children with optic-pathway glioma. A controlled, cross-over clinical trial
- Clinical and molecular determinants of long-term survival in children with low grade glioma; a population based study
- Pediatric patients with diffuse astrocytomas have a distinct clinical course to those diagnosed as adults, with excellent very long term survival
- A multi-institutional Phase II study of vinorelbine in children with recurrent or progressive low-grade gliomas
Unfortunately, videos are not available for these presentations.